| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.93B | 43.06B | 38.89B | 34.31B | 31.67B | 34.08B |
| Gross Profit | 19.65B | 18.27B | 14.19B | 11.28B | 10.40B | 11.13B |
| EBITDA | 10.06B | 9.57B | 6.66B | 4.89B | 4.47B | 4.82B |
| Net Income | 6.78B | 6.41B | 4.67B | 3.17B | 3.03B | 3.32B |
Balance Sheet | ||||||
| Total Assets | 48.55B | 53.57B | 46.63B | 43.59B | 38.90B | 38.00B |
| Cash, Cash Equivalents and Short-Term Investments | 14.00B | 15.54B | 11.83B | 11.48B | 11.55B | 12.51B |
| Total Debt | 752.00M | 644.00M | 755.00M | 425.00M | 382.00M | 450.00M |
| Total Liabilities | 8.81B | 14.07B | 12.16B | 12.51B | 10.03B | 11.34B |
| Stockholders Equity | 39.74B | 39.49B | 34.46B | 31.08B | 28.86B | 26.66B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.01B | 4.17B | 3.44B | 1.26B | 3.94B |
| Operating Cash Flow | 0.00 | 8.13B | 4.27B | 3.52B | 1.36B | 4.10B |
| Investing Cash Flow | 0.00 | -4.28B | -2.12B | -2.20B | -1.44B | -2.38B |
| Financing Cash Flow | 0.00 | -1.64B | -2.11B | -989.00M | -1.07B | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥28.56B | 13.32 | ― | 2.89% | 6.15% | 2.98% | |
80 Outperform | ¥78.74B | 8.26 | ― | 2.31% | 6.50% | 30.54% | |
79 Outperform | ¥106.45B | 15.13 | ― | 3.23% | 7.28% | 4.16% | |
78 Outperform | ¥155.83B | 11.67 | ― | 1.83% | 22.05% | 52.10% | |
72 Outperform | ¥22.91B | 7.24 | ― | 2.84% | 8.78% | 16.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥9.16B | 16.72 | ― | 2.45% | 15.66% | -69.17% |